RA CAPITAL MANAGEMENT, L.P. - 31 Dec 2024 SCHEDULE 13G/A Report for Recursion Pharmaceuticals, Inc. Class A Common Stock, par value $0.00001 per share (RXRX)

Filing Manager
RA CAPITAL MANAGEMENT, L.P.
Reporting Manager
RA Capital Management, L.P.
Security
Recursion Pharmaceuticals, Inc. Class A Common Stock, par value $0.00001 per share
Symbol
RXRX
Shares outstanding
386,254,800 shares
Disclosed Ownership
7,725,096 shares
Ownership
2%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 18:41:24 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Quoteable Key Fact

"RA CAPITAL MANAGEMENT, L.P. disclosed 2% ownership in Recursion Pharmaceuticals, Inc. Class A Common Stock, par value $0.00001 per share (RXRX) on 31 Dec 2024."

Quick Takeaways

  • RA CAPITAL MANAGEMENT, L.P. filed SCHEDULE 13G/A for Recursion Pharmaceuticals, Inc. Class A Common Stock, par value $0.00001 per share (RXRX).
  • Disclosed ownership: 2%.
  • Date of event: 31 Dec 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Feb 2025, 18:41.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
RA Capital Management, L.P. 2% 7,725,096 0 7,725,096 /s/ Peter Kolchinsky By Peter Kolchinsky, Authorized Signatory
Peter Kolchinsky 2% 7,725,096 0 7,725,096 /s/ Peter Kolchinsky Peter Kolchinsky
Rajeev Shah 2% 7,725,096 0 7,725,096 /s/ Rajeev Shah Rajeev Shah
RA Capital Healthcare Fund, L.P. 2% 7,725,096 0 7,725,096 /s/ Peter Kolchinsky By RA Capital Healthcare Fund GP, LLC, its General Partner, By Peter Kolchinsky, Manager